• 1
    King, A., Wellings, V., Gardner, L. and Loke, Y. W., Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum. Immunol. 1989. 24:195205.
  • 2
    King, A., Balendran, N., Wooding, P., Carter, N. P. and Loke, Y. W., CD3-leukocytes present in the human uterus during early placentation: phenotypic and morphological characterization of the CD56++ population. Dev. Immunol. 1991. 1: 169190.
  • 3
    Lash, G. E., Robson, S. C. and Bulmer, J. N., Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta 2010. 31: S87S92.
  • 4
    King, A., Birkby, C. and Loke, Y. W., Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol. 1989. 118: 337344.
  • 5
    King, A., Wooding, P., Gardner, L. and Loke, Y. W., Expression of perforin, granzyme A and TIA-1 by human uterine CD56+NK cells implies they are activated and capable of effector functions. Hum. Reprod. 1993. 8: 206217.
  • 6
    Kopcow, H. D., Allan, D. S., Chen, X., Rybalov, B., Andzelm, M. M., Ge, B. and Strominger, J. L., Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. USA 2005. 102: 1556315568.
  • 7
    Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D. et al., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006. 12: 10651074.
  • 8
    Lash, G. E., Schiessl, D., Kirkley, M., Innes, B. A., Cooper, A., Searle, R. F., Robson, S. C. et al., Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J. Leukoc. Biol. 2006. 80: 572580.
  • 9
    Moffett, A. and Loke, C., Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006. 6: 584594.
  • 10
    Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulphide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 47414745.
  • 11
    King, A., Allen, D. S., Bowen, M., Powis, S. J., Joseph, S., Verma, S., Hiby, S. E. et al., HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 2000. 30: 16231631.
  • 12
    Apps, R., Gardner, L., Sharkey, A. M., Holmes, N. and Moffett, A., A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol. 2007. 37: 19241937.
  • 13
    Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B. and Strominger, J. L., HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 1993. 90: 1200012004.
  • 14
    Mandelboim, O., Reyburn, H. T., Vales-Gomez, M., Pazmany, L., Colonna, M., Borsellino, G. and Strominger, J. L., Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 1996. 184: 913922.
  • 15
    Boyington, J. C., Brooks, A. G. and Sun, P. D., Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol. Rev. 2001. 181: 6678.
  • 16
    Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M. and Parham, P., Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 2008. 180: 39693979.
  • 17
    Schönberg, K., Sribar, M., Enczmann, J., Fischer, J. C. and Uhrberg, M., Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 2010. DOI 10.1182/blood–2010-03-273656.
  • 18
    Hiby, S. E., Walker, J. J., O'shaughnessy, K. M., Redman, C. W., Carrington, M., Trowsdale, J. and Moffett, A., Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004. 200: 957965.
  • 19
    Hiby, S., Regan, L., Lo, W., Farrell, L., Carrington, M. and Moffett, A., Association of maternal KIR and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 2008. 23: 972976.
  • 20
    Hiby, S. E., Apps, R., Sharkey, A. M., Farrell, L. E., Gardner, L., Mulder, A., Claas, F. H. et al., Maternal activating KIR protect against human reproductive failure mediated by fetal HLA-C. J. Clin. Invest. 2010. 120: 41024110.
  • 21
    Verma, S., King, A. and Loke, Y. W., Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur. J. Immunol. 1997. 27: 979983.
  • 22
    Sharkey, A. M., Gardner, L., Hiby, S., Farrell, L., Apps, R., Masters, L., Goodridge, J. et al., Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J. Immunol. 2008. 181: 3946.
  • 23
    Male, V., Hughes, T., McClory, S., Colucci, F., Caligiuri, M. A. and Moffett, A., Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J. Immunol. 2010. 185: 39133918.
  • 24
    Apps, R., Gardner, L. and Moffett, A., A critical look at HLA-G. Trends Immunol. 2008. 29: 313321.
  • 25
    Li, H., Pascal, V., Martin, M. P., Carrington, M. and Anderson, S. K., Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet. 2008. 44: e1000245.
  • 26
    Verma, S., Hiby, S. E., Loke, Y. W. and King, A., Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol. Reprod. 2000. 62: 959968.
  • 27
    Kitaya, K., Yasuda, J., Yagi, I., Tada, Y., Fushiki, S. and Honjo, H., IL-15 expression at human endometrium and decidua. Biol. Reprod. 2000v 63: 683687.
  • 28
    de Rham, C., Ferrari-Lacraz, S., Jendly, S., Schneiter, G., Dayer, J. M., and Villard, J., The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis. Res. Ther. 2007. 9: R125.
  • 29
    Cichocki, F., Hanson, R. J., Lenvik, T., Pitt, M., McCullar, V., Li, H., Anderson, S. K. and Miller, J. S., The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element. Blood 2009. 113: 32453253.
  • 30
    Roth, C., Rothlin, C., Riou, S., Raulet, D. H., and Lemke, G., Stromal cell regulation of natural killer cell differentiation. J. Mol. Med. 2007. 85: 10471056.
  • 31
    Cichocki, F. and Miller, J. S., In vitro development of human killer-immunoglobulin receptor-positive NK cells. Methods Mol. Biol. 2010. 612: 1526.
  • 32
    Thomas, R., Apps, R., Qi, Y., Gao, X., Male, V., O'hUigin, C., O'Connor, G. et al., HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 2009. 41: 12901294.
  • 33
    Corrah, T. W., Goonetilleke, N., Kopycinski, J., Deeks, S. G., Cohen, M. S., Borrow, P., McMichael, A. and Brackenridge, S., Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and suface HLA-C expression. J. Virol. 2011. 85: 33673374.
  • 34
    Braud, V. M., Allan, D. S. J., Wilson, D. and McMichael, A. J., TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 1998. 8: 110.
  • 35
    McGrath, E., Ryan, E. J., Lynch, L., Golden-Mason, L., Mooney, E., Eogan, M., O'Herlihy, C. and O'Farrelly, C., Changes in endometrial natural killer cells expression of CD94, CD158a and CD158b are associated with infertility. Am. J. Reprod. Immunol. 2009. 61: 265276.
  • 36
    Manaster, I., Mizrahi, S., Goldman-Wohl, D., Sela, H. Y., Stern-Ginossar, N., Lankry, D., Gruda, R. et al., Endometrial NK cells are special immature cells that await pregnancy. J. Immunol. 2008. 181: 18691876.
  • 37
    Yang, J. H., Chen, M. J., Chen, H. F., Lee, T. H., Ho, H. N. and Yang, Y. S., Decreased expression of killer inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum. Reprod. 2004. 19: 19741978.
  • 38
    Eriksson, M., Meadows, S. K., Wira, C. R. and Sentman, C. L., Unique phenotype of human uterine NK cells are their regulation by endogenous TGF-beta. J. Leukoc. Biol. 2004. 76: 667675.
  • 39
    Rosen, D. B., Bettadapura, J., Alsharifi, M., Matthew, P. A., Warren, H. S. and Lanier, L. L., Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 2005. 175: 77967799.
  • 40
    Apps, R., Sharkey, A., Gardner, L., Male, V., Trotter, M., Miller, N., North, R. et al., Genome-wide expression profile of first trimester villous and extravillous human trophoblast cells. Placenta 2011. 32: 3343.
  • 41
    Yadi, H., Burke, S., Madeja, Z., Hemberger, M., Moffett, A. and Colucci, F., Unique receptor repertoire in mouse uterine NK cells. J. Immunol. 2008. 181: 61406147.
  • 42
    Kopcow, H. D., Erikkson, M., Mselle, T. F., Damrauer, S. M., Wira, C. R., Sentman, C. L. and Strominger, J. L., Human decidual NK cell from gravid uteri and NK cells from cycling endometrium are distinct NK cell subsets. Placenta 2010. 31: 334338.
  • 43
    Vacca, P., Pietra, G., Falco, M., Romeo, E., Bottino, C., Bellora, F., Prefumo, F. et al., Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006. 108: 40784085.
  • 44
    Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Orange, J. S., Schatz, F., Masch, R. et al., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003. 198: 12011212.
  • 45
    El Costa, H., Casemayou, A., Aguerre-Girr, M., Rabot, M., Berrebi, A., Parant, O., Clouet-Delannoy, M. et al., Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J. Immunol. 2008. 181: 30093017.
  • 46
    Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Casticoni, R., Marcenaro, E., Augugliaro, R. et al., NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 1998. 187: 20652072.
  • 47
    Crellin, N. K., Trifari, S., Kaplan, C. D., Cupedo, T. and Spits, H., Human NKp44+IL-22+cells and LTi-like cells constitute a stable RORC+lineage distinct from conventional natural killer cells. J. Exp. Med. 2010. 207: 281290.
  • 48
    Miller, J. S. and McCullar, V., Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single haematopoietic stem cells with preferential expansion of NKG2A and KIR2DL2/L3/S2. Blood 2001 98:705713.
  • 49
    Fischer, J. C., Ottinger, H., Ferencik, S., Sribar, M., Punzel, M., Beelan, D. W., Schwann, M. A. et al., Relevance of C1 and C2 epitopes for hematopoietic stem cell transplantation: role for sequential acquisition of HLA-C specific inhibitory killer Ig-like receptors. J. Immunol. 2009. 178: 39183923.
  • 50
    Stern, M., de Angelis, C., Urbani, E., Mancusi, A., Aversa, F., Velardi, A. and Ruggeri, L., Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. Bone Marrow Transplant. 2010. 45: 16071610.
  • 51
    Tilburgs, T., van der Mast, B. J., Nagtzaam, N. M., Roelen, D. L., Scherjon, S. A. and Claas, F. H., Expression of NK cell receptors on decidual T cells in human pregnancy. J. Reprod. Immunol. 2009. 80: 2232.
  • 52
    Borthwick, J. M., Charnock-Jones, D. S., Tom, B. D., Hull, M. L., Teirney, R., Phillips, S. C. and Smith, S. K., Determination of the transcript profile of human endometrium. Mol. Hum. Reprod. 2003. 9: 1933.
  • 53
    Henderson, T. A., Saunders, P. T., Moffett-King, A., Groome, N. P. and Critchley, H. O., Steroid receptor expression in uterine natural killer cells. J. Clin. Endocrinol. Metab. 2003. 88: 440449.
  • 54
    Milne, S. A., Henderson, T. A., Kelly, R. W., Saunders, P. T., Baird, D. T. and Critchley, H. O., Leukocyte populations and steroid receptor expression in human first-trimester decidua: regulation by antiprogestin and prostaglandin E analog. J. Clin. Endocrinol. Metab. 2005. 90: 43154321.
  • 55
    Spornitz, U. M., The functional morphology of the human endometrium and decidua. Adv. Anat. Embryol. Cell Biol. 1992. 124: 199.
  • 56
    Burrows, T., King, A. and Loke, Y. W., The role of integrins in adhesion of decidual NK cells to extracellular matrix and decidual stromal cells. Cell Immunol. 1995. 166: 5361.
  • 57
    Keskin, D. B., Allan, D. S., Rybalov, B., Andzelm, M. M., Stern, J. N., Kopcow, H. D., Koopman, L. A. and Strominger, J. L., TGFbeta promotes conversion of CD16+peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells. Proc. Natl. Acad. Sci. USA 2007. 104: 33783383.
  • 58
    Male, V., Trundley, A., Gardner, L., Northfield, J., Chang, C., Apps, R. and Moffett, A., Natural killer cells in human pregnancy. Methods Mol. Biol. 2010. 612: 4474463.
  • 59
    Apps, R., Gardner, L., Traherne, J., Male, V. and Moffett, A., Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum. Reprod. 2008. 23: 25352548.
  • 60
    Sharkey, A. M., Jokhi, P. P., King, A., Loke, Y. W., Brown, K. D. and Smith, S. K., Expression of c-kit and kit ligand at the human maternofetal interface. Cytokine 1994. 6: 195205.
  • 61
    Bulmer, J. N., Williams, P. J. and Lash, G. E., Immune cells in the placental bed. Int. J. Dev. Biol. 2010. 54: 281294.